# Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF)

> **NCT00296478** · PHASE3 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 1211 (actual)

## Conditions studied

- Fertility

## Interventions

- **DRUG:** Endometrin
- **DRUG:** Endometrin
- **DRUG:** Crinone

## Key facts

- **NCT ID:** NCT00296478
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2006-04
- **Final completion:** 2006-07
- **Target enrollment:** 1211 (ACTUAL)
- **Last updated:** 2011-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00296478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00296478, "Multi-Center, Randomized, Open-Label, Parallel Group Study of a Vaginal Micronized Progesterone Tablet (Endometrin®) Compared to Crinone 8% Vaginal Gel in Female Patients Undergoing In-Vitro Fertilization (IVF)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00296478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*